SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-016564
Filing Date
2019-05-07
Accepted
2019-05-07 16:36:30
Documents
73
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eidx-10q_20190331.htm 10-Q 1851845
2 EX-31.1 eidx-ex311_6.htm EX-31.1 17872
3 EX-31.2 eidx-ex312_7.htm EX-31.2 17949
4 EX-32.1 eidx-ex321_8.htm EX-32.1 9940
5 EX-32.2 eidx-ex322_9.htm EX-32.2 9922
  Complete submission text file 0001564590-19-016564.txt   6690935

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eidx-20190331.xml EX-101.INS 1336219
7 XBRL TAXONOMY EXTENSION SCHEMA eidx-20190331.xsd EX-101.SCH 64439
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eidx-20190331_cal.xml EX-101.CAL 38568
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eidx-20190331_def.xml EX-101.DEF 203693
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eidx-20190331_lab.xml EX-101.LAB 443992
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eidx-20190331_pre.xml EX-101.PRE 351588
Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Filer) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38533 | Film No.: 19803653
SIC: 2834 Pharmaceutical Preparations